These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 38044666

  • 1. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
    Hao W, Yu TT, Zuo DZ, Hu HZ, Zhou PP.
    Exp Lung Res; 2023 Nov 20; 49(1):205-219. PubMed ID: 38044666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
    Zhang Q, Ye W, Liu Y, Niu D, Zhao X, Li G, Qu Y, Zhao Z.
    Biomed Pharmacother; 2023 Jan 20; 157():114018. PubMed ID: 36410121
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
    Tang H, Gao L, Mao J, He H, Liu J, Cai X, Lin H, Wu T.
    Cell Stress Chaperones; 2016 Mar 20; 21(2):239-49. PubMed ID: 26577463
    [Abstract] [Full Text] [Related]

  • 6. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G.
    J Pharm Pharmacol; 2019 Jun 20; 71(6):1017-1028. PubMed ID: 30847938
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Research on ameliorating pulmonary fibrosis in silicosis mice of Cordyceps cicadae polysaccharides].
    Cao L, Wang GL, Chen L, Liu SP.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Sep 20; 42(9):641-649. PubMed ID: 39394701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways.
    Jia C, Yang M, Xiao G, Zeng Z, Li L, Li Y, Jiang J, Xu A, Qiu J, Tang R, Li D, Jia D, Xie C, Wu G, Cai D, Bi X.
    Phytomedicine; 2024 Sep 20; 132():155545. PubMed ID: 38972238
    [Abstract] [Full Text] [Related]

  • 15. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
    Tang J, Ke J, Fu Y, He XW, Li XW.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov 20; 37(6):577-583. PubMed ID: 34821087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.
    Int Immunopharmacol; 2014 Oct 20; 22(2):498-504. PubMed ID: 25111852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 20; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.